FDAnews
www.fdanews.com/articles/179263-channel-medsystems-secures-ide-approval-for-the-clarity-pivotal-study

Channel Medsystems Secures IDE Approval for the Clarity Pivotal Study

November 14, 2016

Channel has revealed the treatment of the first subjects in the US phase of its Clarity Pivotal Study which was to evaluate the safety and effectiveness of the Cerene Cryotherapy Device for endometrial ablation in women with heavy menstrual bleeding who are finished with childbearing.

The device was designed to provide an analgesic effect.

Treatment with cryothermic energy has been shown to reduce the likelihood of scarring and intrauterine adhesions that are often associated with heat-based endometrial ablation. — Cynthia Jessup

View today's stories